IDNA vs VXUS
iShares Genomics Immunology and Healthcare ETF vs Vanguard Total International Stock ETF
Quick Verdict
VXUS has a lower expense ratio. IDNA delivered stronger 1-year returns. VXUS offers more diversification with 7861 holdings.
Side-by-Side Comparison
| Metric | IDNA | VXUS | Winner |
|---|---|---|---|
| Expense Ratio | 0.47% | 0.05% | |
| AUM | $190M | $156.5B | |
| Dividend Yield | 0.83% | 2.60% | |
| Holdings | 62 | 8,747 | |
| YTD Return | +35.66% | +15.00% | |
| 1Y Return | +65.26% | +26.87% | |
| 3Y Return (annualized) | +18.26% | +19.79% | |
| 5Y Return (annualized) | -6.91% | +9.26% | |
| Volatility (annualized) | 25.2% | 15.1% | |
| Max Drawdown | -68.3% | -39.9% | |
| Fund Family | iShares by BlackRock (US) | Vanguard (US) | |
| Category | Equity | Equity | |
| Inception | Jun 11, 2019 | Jan 26, 2011 |
IDNA vs VXUS Performance
iShares Genomics Immunology and Healthcare ETF (IDNA) is a ETF from iShares by BlackRock (US) and Vanguard Total International Stock ETF (VXUS) is a ETF from Vanguard (US). Over the past year IDNA returned +65.26% while VXUS returned +26.87%. Year to date, IDNA is up 35.66% versus a gain of 15.00% for VXUS.
Over three years, IDNA compounded at +18.26% per year against +19.79% for VXUS; over five years the annualized figures are -6.91% and +9.26% respectively. Across the full 7-year window we track, IDNA has the edge at +5.75% annualized vs +4.88%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
IDNA has been the more volatile fund, with annualized monthly volatility of 25.2% compared with 15.1% for VXUS. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -68.3% for IDNA and -39.9% for VXUS. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.59. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
IDNA charges 0.47% per year while VXUS charges 0.05%. On a $10,000 position that is $47 vs $5 annually, a gap of $42 per year that compounds over a long holding period. On income, IDNA currently yields 0.83% against 2.60% for VXUS.
Holdings Overlap
IDNA and VXUS share 7 holdings out of 7902 unique holdings combined, representing a 0.5% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, IDNA or VXUS?
IDNA has an expense ratio of 0.47% while VXUS charges 0.05%. VXUS is the cheaper option. On a $10,000 investment, that is $42 per year of difference.
Which performed better, IDNA or VXUS?
Over the past year IDNA returned +65.26% vs +26.87% for VXUS, so IDNA leads on 1-year performance. Over the longest common window we track (7 years), IDNA annualized +5.75% vs +4.88% for VXUS. Past performance does not guarantee future results.
Which is riskier, IDNA or VXUS?
IDNA has been the more volatile fund at 25.2% annualized versus 15.1% for VXUS. Worst drawdown: IDNA -68.3% vs VXUS -39.9%.
Should I hold both IDNA and VXUS?
IDNA and VXUS have a monthly-return correlation of 0.59, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between IDNA and VXUS?
IDNA and VXUS share 7 common holdings with a 0.5% weight overlap. Combined, they hold 7902 unique securities.
Which pays a higher dividend, IDNA or VXUS?
IDNA yields 0.83% while VXUS yields 2.60%, so VXUS currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.